Levstik A, Stuart A, Adams PC

Language: English
References: 11
Page: 907-910
PDF size: 129.11 Kb.

ABSTRACT

Background. Previous studies in high and low expressors has demonstrated that a variant in the GNPAT gene (D519G, Rs11558492, chromosome 1, exon 11) has been associated with severe iron overload in C282Y homozygotes for hemochromatosis. In this study, a GNPAT variant was assessed prospectively in patients referred for HFE testing over a range of serum ferritin levels. Material and methods. Consecutive patients sent for HFE testing were studied for the GNPAT variant using a TaqMan kit assay (Life Technologies, Burlington, ON). Serum ferritin and iron removed by phlebotomy was compared in C282Y homozygotes with and without the GNPAT variant. The frequency of the GNPAT variant in referred patients was compared to a control population of voluntary blood donors without HFE mutations. Results. There were 533 patients that had GNPAT analysis. The allele frequency for the GNPAT variant in C282Y homozygotes (n = 75) was 0.226 and in wild type control patients (n = 458) was 0.213 (p = .07). Forty-eight percent (of the C282Y homozygotes were heterozygous (n = 28) or homozygous (n = 8) for the GNPAT variant. The mean (log)ferritin and iron removed did not significantly differ between C282Y homozygous with GNPAT homozygotes, GNPAT heterozygotes, and without the GNPAT variant (p = 0.84). Conclusions. C282Y homozygotes referred for HFE testing commonly have a GNPAT variant. This GNPAT variant does not appear be a co-modifying gene affecting expression of HFE related hemochromatosis in this population. The GNPAT variant does not predict the severity of iron overload.

REFERENCES

1. Pietrangelo A. Genetics, Genetic Testing and Management of Hemochromatosis: 15 years since hepcidin. Gastroenterology 2015; 1240-51.

2. Barton JC, Lafreniere SA, Leiendecker-Foster C, Li H, Acton RT, Press RD, Eckfeldt JH. HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants. Am J Hematol 2009; 710-14.

3. de TM, Roth MP, Jouanolle AM, Coppin H, le GG, Piperno A, Ferec C, et al. Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis. J Hepatol 2015; 62: 664-72.

4. McLaren C, Emond M, Subramanian N, Phatak P, Barton JC, Adams PC, Goh JB, et al. Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe Iron overload. Hepatology 2015; 62: 429-39.

5. Ryan J, Russell J, Ryan J, Crowe J, Stewart S. GNPAT variant is not associated with severe iron ovelroad in Irish C282Y homozygotes. Hepatology 2016: 63; 2055-6.

6. Besson C, Martinez M. Further support for the association of GNPAT variant rs11558492 with severe iron overload in hemochromatosis. Hepatology 2016: 63; 2054-5.

7. Bardou-Jacquet E, De Tayrac M, Mosser J, Deugnier Y. GNPAT Variant associated with severe iron overload in HFE hemochromatosis. Hepatology 2015; 62: 1917-8.

8. Hsiao S, Lee CT, Pei S. GNPAT variant is associated with iron phenotyp in healthy Taiwanese women: A population without the HFE C282Y mutation. Hepatology 2016: 63; 2057-8.

9. Ravasi G, Pelucchi S, Trombini P, Mariani R, Tomosugi N, Modignani GL, Pozzi M, et al. Hepcidin expression in iron overload diseases is variably modulated by circulating factors. PLoS One 2012; 7: e36425.

10. Vermeulen E, Vermeersch P. Hepcidin as a biomarker for the diagnosis of iron metabolism disorders: a review. Acta Clin Belg 2012; 67: 190-7.

11. Handa P, Kowdley KV. Glyceronephosphate O-acyltransferase as a hemochromatosis modifier gene: Another iron in the fire? Hepatology 2015; 62: 337-9.